At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 110 target
Drug / intervention
Pulsed electromagnetic fields Thearpy +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Randomized Study to Investigate the Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
In Brief
A clinical study evaluating Pulsed electromagnetic fields Thearpy and Sham Therapy for Prostate Cancer. Currently recruiting, targeting 110 participants across 1 site.
Detailed Summary
This study is to assess the effect of Pulsed electromagnetic fields (PEMF) on improving muscle mass and strength in prostate cancer patients with ADT.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesHong Kong
Collaborators--
Timeline
N/ARecruiting
20262027
Enrollment StartJun 2025
First PostedJul 2025
TodayJul 2026
Primary CompletionDec 2026
Study CompletionMar 2027
First PostedJul 9, 2025
Enrollment StartJun 1, 2025
Primary CompletionDec 31, 2026
Study CompletionMar 31, 2027
TodayJul 1, 2026
Enrollment to primary: 1.6 yearsPosted 12 months agoPrimary completion in 6 months
Interventions
Pulsed electromagnetic fields Thearpydevice
Pulsed electromagnetic fields (PEMF) is a non-invasive and non-thermal treatment used to stimulate muscle regeneration, resulting in increased muscle mass and strength.
Sham Therapydevice
Sham Therapy